Fundraising FoxPneumaCare
Cambridge, GB · 2 known investors
Find your way into PneumaCare
Sign up to see every warm intro you have to PneumaCare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PneumaCare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.
Founders & leadership
BA
Bart A. LewinChief Executive OfficerBart A. Lewin is CEO of PneumaCare, which develops 3D imaging technology for non-invasive lung function assessment in hospital settings. He has previously founded and exited multiple technology companies and held management consulting roles across IT and technical operations.
Investors · 2
In the news
Frequently asked questions
- What does PneumaCare do?
- PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings. The company serves clinicians assessing respiratory conditions such as COPD, with a UK/Cambridge base.
- Who are PneumaCare's investors?
- PneumaCare's investors include Cambridge Angels group, Cambridge Capital Group.
- Where is PneumaCare headquartered?
- PneumaCare is headquartered in Cambridge, GB.